- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 7/02 - Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Patent holdings for IPC class A61P 7/02
Total number of patents in this class: 2778
10-year publication summary
|
120
|
109
|
111
|
130
|
165
|
179
|
162
|
184
|
171
|
55
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1829 |
75 |
| Bristol-myers Squibb Company | 5080 |
74 |
| Takeda Pharmaceutical Company Limited | 2961 |
38 |
| AstraZeneca AB | 3042 |
36 |
| Bayer Pharma AG | 1096 |
36 |
| Boehringer Ingelheim International GmbH | 4629 |
31 |
| Bayer Healthcare AG | 271 |
21 |
| Sanofi | 3836 |
18 |
| Merck Sharp & Dohme Corp. | 2247 |
17 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 790 |
17 |
| Janssen Pharmaceutica N.V. | 3839 |
17 |
| Ono Pharmaceutical Co., Ltd. | 454 |
17 |
| Merck Sharp & Dohme LLC | 3689 |
17 |
| Mochida Pharmaceutical Co., Ltd. | 334 |
16 |
| Novartis AG | 11238 |
15 |
| F. Hoffmann-La Roche AG | 7958 |
15 |
| Bayer AG | 3045 |
15 |
| Astellas Pharma Inc. | 1145 |
15 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
15 |
| Sunshine Lake Pharma Co., Ltd. | 542 |
15 |
| Other owners | 2258 |